Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

Suppr

超能文献

作者信息

Rossi J J, Sarver N

机构信息

Department of Molecular Genetics, Beckman Research Institute of the City of Hope, Duarte, CA 91010.

出版信息

Adv Exp Med Biol. 1992;312:95-109. doi: 10.1007/978-1-4615-3462-4_9.

DOI:10.1007/978-1-4615-3462-4_9

PMID:1514448

Abstract

摘要

相似文献

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

Adv Exp Med Biol. 1992;312:95-109. doi: 10.1007/978-1-4615-3462-4_9.

Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.

Antisense Res Dev. 1991 Fall;1(3):285-8.

Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.

Inflamm Res. 1995 Jan;44(1):11-5. doi: 10.1007/BF01630480.

Therapeutic applications of catalytic antisense RNAs (ribozymes).

Ciba Found Symp. 1997;209:195-204; discussion 204-6. doi: 10.1002/9780470515396.ch14.

RNA enzymes (ribozymes) as antiviral therapeutic agents.

Trends Biotechnol. 1990 Jul;8(7):179-83. doi: 10.1016/0167-7799(90)90169-x.

Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.

Ann N Y Acad Sci. 1992 Oct 28;660:95-106. doi: 10.1111/j.1749-6632.1992.tb21062.x.

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.

AIDS Res Hum Retroviruses. 1992 Feb;8(2):183-9. doi: 10.1089/aid.1992.8.183.

Gene therapy for HIV.

Sex Transm Infect. 2001 Apr;77(2):93-6. doi: 10.1136/sti.77.2.93.

Inhibition of gene expression with ribozymes.

Cell Mol Neurobiol. 1994 Oct;14(5):523-38. doi: 10.1007/BF02088835.

Biological applications of hammerhead ribozymes as anti-viral molecules.

Curr Med Chem. 2001 Aug;8(10):1181-7. doi: 10.2174/0929867013372373.

引用本文的文献

Multidimensional futuristic approaches to address the pandemics beyond COVID-19.

Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.

Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.

Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1189-94. doi: 10.1073/pnas.95.3.1189.

Activation of HIV-specific ribozyme activity by self-cleavage.

Nucleic Acids Res. 1993 Jul 11;21(14):3249-55. doi: 10.1093/nar/21.14.3249.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

Adv Exp Med Biol. 1992;312:95-109. doi: 10.1007/978-1-4615-3462-4_9.

Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.

Antisense Res Dev. 1991 Fall;1(3):285-8.

Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.

Inflamm Res. 1995 Jan;44(1):11-5. doi: 10.1007/BF01630480.

Therapeutic applications of catalytic antisense RNAs (ribozymes).

Ciba Found Symp. 1997;209:195-204; discussion 204-6. doi: 10.1002/9780470515396.ch14.

RNA enzymes (ribozymes) as antiviral therapeutic agents.

Trends Biotechnol. 1990 Jul;8(7):179-83. doi: 10.1016/0167-7799(90)90169-x.

Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.

Ann N Y Acad Sci. 1992 Oct 28;660:95-106. doi: 10.1111/j.1749-6632.1992.tb21062.x.

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.

AIDS Res Hum Retroviruses. 1992 Feb;8(2):183-9. doi: 10.1089/aid.1992.8.183.

Gene therapy for HIV.

Sex Transm Infect. 2001 Apr;77(2):93-6. doi: 10.1136/sti.77.2.93.

Inhibition of gene expression with ribozymes.

Cell Mol Neurobiol. 1994 Oct;14(5):523-38. doi: 10.1007/BF02088835.

Biological applications of hammerhead ribozymes as anti-viral molecules.

Curr Med Chem. 2001 Aug;8(10):1181-7. doi: 10.2174/0929867013372373.

引用本文的文献

Multidimensional futuristic approaches to address the pandemics beyond COVID-19.

Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.

Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.

Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1189-94. doi: 10.1073/pnas.95.3.1189.

Activation of HIV-specific ribozyme activity by self-cleavage.

Nucleic Acids Res. 1993 Jul 11;21(14):3249-55. doi: 10.1093/nar/21.14.3249.